Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Transnational Corporations Eye Traditional Chinese Medicine Biz (China)

This article was originally published in PharmAsia News

Executive Summary

In the past 10 years there has been increasing global interest in the uses of traditional Chinese medicine (TCM), particularly in the country's vast supply of medicinal plants. According to a study by the Beijing Pharmaceutical Professional Association, the world's 15 leading pharmaceutical companies have increased their research into plant-based medications by 22 percent. Regulatory bodies around the world have also relaxed regulations on TCM products, leading more international companies to invest in their development. (Print Edition Only: Link to Full Text Unavailable

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066454

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel